Inactief instrument

Koers Cascadian Therapeutics Inc (USA)

Aandelen

Duur

Periode

Stijl

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04-01-18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02-01-18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13-12-17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07-12-17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08-11-17

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	-3,30%	102 mld.
REGENERON PHARMACEUTICALS, INC.	+1,79%	96,84 mld.
ARGENX SE	-0,44%	21,48 mld.
BIONTECH SE	-18,35%	20,82 mld.
GENMAB A/S	-7,45%	18,6 mld.
WUXI APPTEC CO., LTD.	-40,31%	16,81 mld.
BEIGENE, LTD.	-26,84%	13,78 mld.
NEUROCRINE BIOSCIENCES, INC.	+0,59%	13,4 mld.
SAREPTA THERAPEUTICS, INC.	+20,86%	11,06 mld.